<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39458369</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>Usefulness of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in Predicting the Outcome in Subjects Hospitalized with COVID-19-A Subanalysis of the COLOS Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2060</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms12102060</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The aim of this study was to see if the CHA<sub>2</sub>DS<sub>2</sub>-VASc score (Cardiac failure or dysfunction, Hypertension, Age ≥ 75 [Doubled], Diabetes, Stroke [Doubled]-Vascular disease, Age 65-74 and Sex category [Female] score) could have potential clinical relevance in predicting the outcome of hospitalization time, need for ICU hospitalization, survival time, in-hospital mortality, and mortality at 3 and 6 months after discharge home.</AbstractText><AbstractText Label="MATERIALS" NlmCategory="METHODS">A retrospective analysis of 2183 patients with COVID-19 hospitalized at the COVID-19 Centre of the University Hospital in Wrocław, Poland, between February 2020 and June 2021, was performed. All medical records were collected as part of the COronavirus in LOwer Silesia-the COLOS registry project. The CHA<sub>2</sub>DS<sub>2</sub>-VASc score was applied for all subjects, and the patients were observed from admission to hospital until the day of discharge or death. Further information on patient deaths was prospectively collected following the 90 and 180 days after admission. The new risk stratification derived from differences in survival curves and long-term follow-up of our patients was obtained. Primary outcomes measured included in-hospital mortality and 3-month and 6-month all-cause mortality, whereas secondary outcomes included termination of hospitalization from causes other than death (home discharges/transfer to another facility or deterioration/referral to rehabilitation) and non-fatal adverse events during hospitalization.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">It was shown that gender had no effect on mortality. Significantly shorter hospitalization time was observed in the group of patients with low CHA<sub>2</sub>DS<sub>2</sub>-VASc scores. Among secondary outcomes, CHA<sub>2</sub>DS<sub>2</sub>-VASc score revealed predictive value in both genders for cardiogenic (5.79% vs. 0.69%; <i>p</i> &lt; 0.0001), stroke/TIA (0.48% vs. 9.92%; <i>p</i> &lt; 0.0001), acute heart failure (0.97% vs. 18.18%; <i>p</i> &lt; 0.0001), pneumonia (43% vs. 63.64%; <i>p</i> &lt; 0.0001), and acute renal failure (7.04% vs. 23.97%; <i>p</i> &lt; 0.0001). This study points at the usefulness of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score in predicting the severity of the course of COVID-19.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Routine use of this scale in clinical practice may suggest the legitimacy of extending its application to the assessment of not only the risk of thromboembolic events in the COVID-19 cohort.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Resler</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-1399-5524</Identifier><AffiliationInfo><Affiliation>Clinical Department of Otolaryngology, Head and Neck Surgery, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lubieniecki</LastName><ForeName>Pawel</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-5911-3902</Identifier><AffiliationInfo><Affiliation>Clinical Department of Diabetology and Internal Disease, University Hospital, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zatonski</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3043-4806</Identifier><AffiliationInfo><Affiliation>Clinical Department of Otolaryngology, Head and Neck Surgery, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doroszko</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5472-028X</Identifier><AffiliationInfo><Affiliation>Clinical Department of Cardiology, 4th Military Hospital, Faculty of Medicine, Wroclaw University of Science and Technology, Weigla 5 Street, 50-981 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trocha</LastName><ForeName>Malgorzata</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3951-205X</Identifier><AffiliationInfo><Affiliation>Clinical Department of Diabetology and Internal Disease, University Hospital, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skarupski</LastName><ForeName>Marek</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1569-9216</Identifier><AffiliationInfo><Affiliation>Faculty of Pure and Applied Mathematics, Wroclaw University of Science and Technology, 50-376 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kujawa</LastName><ForeName>Krzysztof</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2812-4702</Identifier><AffiliationInfo><Affiliation>Statistical Analysis Centre, Wroclaw Medical University, K. Marcinkowski Street 2-6, 50-368 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabczynski</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Department of Diabetology and Internal Disease, University Hospital, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuznik</LastName><ForeName>Edwin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinical Department of Diabetology and Internal Disease, University Hospital, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bednarska-Chabowska</LastName><ForeName>Dorota</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clinical Department of Diabetology and Internal Disease, University Hospital, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madziarski</LastName><ForeName>Marcin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2434-8725</Identifier><AffiliationInfo><Affiliation>Clinical Department of Rheumatology and Internal Medicine, University Hospital, Borowska Street 213, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trocha</LastName><ForeName>Tymoteusz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sokolowski</LastName><ForeName>Janusz</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jankowska</LastName><ForeName>Ewa A</ForeName><Initials>EA</Initials><Identifier Source="ORCID">0000-0002-9202-432X</Identifier><AffiliationInfo><Affiliation>Institute of Heart Diseases, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madziarska</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3624-3691</Identifier><AffiliationInfo><Affiliation>Clinical Department of Diabetology and Internal Disease, University Hospital, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CHA2DS2-VASc—score</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV2</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39458369</ArticleId><ArticleId IdType="pmc">PMC11510264</ArticleId><ArticleId IdType="doi">10.3390/microorganisms12102060</ArticleId><ArticleId IdType="pii">microorganisms12102060</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fraser R., Orta-Resendiz A., Dockrell D., Müller-Trutwin M., Mazein A. Severe COVID-19 versus multisystem inflammatory syndrome: Comparing two critical outcomes of SARS-CoV-2 infection. Eur. Respir. Rev. 2023;32:220197. doi: 10.1183/16000617.0197-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0197-2022</ArticleId><ArticleId IdType="pmc">PMC10032586</ArticleId><ArticleId IdType="pubmed">36889788</ArticleId></ArticleIdList></Reference><Reference><Citation>Umakanthan S., Sahu P., Ranade A.V., Bukelo M.M., Rao J.S., Lf A.-M., Dahal S., Kumar H., Kv D. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19) Postgrad. Med. J. 2020;96:753–758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10016932</ArticleId><ArticleId IdType="pubmed">32563999</ArticleId></ArticleIdList></Reference><Reference><Citation>Okarska-Napierała M., Ludwikowska K.M., Szenborn L., Dudek N., Mania A., Buda P., Książyk J., Mazur-Malewska K., Figlerowicz M., Szczukocki M., et al. Pediatric Inflammatory Multisystem Syndrome (PIMS) Did Occur in Poland during Months with Low COVID-19 Prevalence, Preliminary Results of a Nationwide Register. J. Clin. Med. 2020;9:3386. doi: 10.3390/jcm9113386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9113386</ArticleId><ArticleId IdType="pmc">PMC7690437</ArticleId><ArticleId IdType="pubmed">33105634</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y.-D., Ding M., Dong X., Zhang J.-J., Azkur A.K., Azkur D., Gan H., Sun Y.-L., Fu W., Li W., et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021;76:428–455. doi: 10.1111/all.14657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14657</ArticleId><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Asakura H., Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int. J. Hematol. 2021;113:45–57. doi: 10.1007/s12185-020-03029-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12185-020-03029-y</ArticleId><ArticleId IdType="pmc">PMC7648664</ArticleId><ArticleId IdType="pubmed">33161508</ArticleId></ArticleIdList></Reference><Reference><Citation>Gómez-Mesa J.E., Galindo-Coral S., Montes M.C., Martin A.J.M. Thrombosis and Coagulopathy in COVID-19. Curr. Probl. Cardiol. 2021;46:100742. doi: 10.1016/j.cpcardiol.2020.100742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2020.100742</ArticleId><ArticleId IdType="pmc">PMC7605852</ArticleId><ArticleId IdType="pubmed">33243440</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P., Schwartz R.A. Disseminated intravascular coagulation: A devastating systemic disorder of special concern with COVID-19. Dermatol. Ther. 2020;33:e14053. doi: 10.1111/dth.14053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dth.14053</ArticleId><ArticleId IdType="pmc">PMC7404500</ArticleId><ArticleId IdType="pubmed">32700813</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter J., Combs C.A., Kahn B., Maurel K., Clark R. Disseminated intravascular coagulation complicating mild or asymptomatic maternal COVID-19. AJOG Glob. Rep. 2022;2:100110. doi: 10.1016/j.xagr.2022.100110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xagr.2022.100110</ArticleId><ArticleId IdType="pmc">PMC9502436</ArticleId><ArticleId IdType="pubmed">36168543</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori H., Ohkawara H., Togawa R., Rikimaru M., Shibata Y., Ikezoe T. Diagnosis and treatment of disseminated intravascular coagulation in COVID-19 patients: A scoping review. Int. J. Hematol. 2021;113:320–329. doi: 10.1007/s12185-021-03084-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12185-021-03084-z</ArticleId><ArticleId IdType="pmc">PMC7868079</ArticleId><ArticleId IdType="pubmed">33550533</ArticleId></ArticleIdList></Reference><Reference><Citation>Lip G.Y.H., Nieuwlaat R., Pisters R., Lane D.A., Crijns H.J.G.M. Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach: The Euro Heart Survey on atrial fibrillation. Chest. 2010;137:263–272. doi: 10.1378/chest.09-1584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.09-1584</ArticleId><ArticleId IdType="pubmed">19762550</ArticleId></ArticleIdList></Reference><Reference><Citation>Arcari L., Luciani M., Cacciotti L., Musumeci M.B., Spuntarelli V., Bentivegna E., Camastra G., Ansalone G., Santini C., Martelletti P., et al. CHA2DS2-VASc score in patients with COVID-19 pneumonia and its relationship with biomarkers of thrombosis, inflammation and myocardial injury. Blood Coagul. Fibrinolysis. 2022;33:188–192. doi: 10.1097/MBC.0000000000001098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0000000000001098</ArticleId><ArticleId IdType="pubmed">34693913</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva B.V., Plácido R., Jorge C., Mendonça C., Urbano M.L., Rodrigues T., Brito J., da Silva P.A., Rigueira J., Pinto F.J. Prognostic Accuracy of the Modified CHA2DS2-VASc Score in COVID-19 Patients Admitted to the Emergency Department Due to Clinical Worsening. Acta Med. Port. 2022;35:433–442. doi: 10.20344/amp.17016.</Citation><ArticleIdList><ArticleId IdType="doi">10.20344/amp.17016</ArticleId><ArticleId IdType="pubmed">34837357</ArticleId></ArticleIdList></Reference><Reference><Citation>Genç Ö., Yildirim A., Genç M., Er F., Alici G., Quisi A., Harbalioğlu H., Allahverdiyev S., Kurt I.H. Comparison of Thromboembolic Risk Scores for Evaluating In-Hospital Events of Covid-19 Patients. Biomark. Med. 2023;17:59–72. doi: 10.2217/bmm-2022-0546.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm-2022-0546</ArticleId><ArticleId IdType="pubmed">37038968</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecconi M., Evans L., Levy M., Rhodes A. Sepsis and septic shock. Lancet. 2018;392:75–87. doi: 10.1016/S0140-6736(18)30696-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)30696-2</ArticleId><ArticleId IdType="pubmed">29937192</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides S.V., Meyer G., Becattini C., Bueno H., Geersing G.J., Harjola V.-P., Huisman M.V., Humbert M., Jennings C.S., Jiménez D., et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) Eur. Heart J. 2020;41:543–603. doi: 10.1093/eurheartj/ehz405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz405</ArticleId><ArticleId IdType="pubmed">31504429</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K., Alpert J.S., Jaffe A.S., Chaitman B.R., Bax J.J., Morrow D.A., White H.D., Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction Fourth Universal Definition of Myocardial Infarction. J. Am. Coll. Cardiol. 2018;72:2231–2264. doi: 10.1016/j.jacc.2018.08.1038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.08.1038</ArticleId><ArticleId IdType="pubmed">30153967</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., Böhm M., Burri H., Butler J., Čelutkienė J., Chioncel O., et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2021;42:3599–3726. doi: 10.1093/eurheartj/ehab368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab368</ArticleId><ArticleId IdType="pubmed">34447992</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers W.J., Rabinstein A.A., Ackerson T., Adeoye O.M., Bambakidis N.C., Becker K., Biller J., Brown M., Demaerschalk B.M., Hoh B., et al. Guidelines for the Early Management of Patients with Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50:e344–e418. doi: 10.1161/str.0000000000000211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/str.0000000000000211</ArticleId><ArticleId IdType="pubmed">31662037</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell E.J. Respiratory failure. Definition, mechanisms and recent developments. Bull Eur. Physiopathol. Respir. 1979;15:1–13.</Citation><ArticleIdList><ArticleId IdType="pubmed">122061</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty R.K., Burns B. Systemic Inflammatory Response Syndrome. StatPearls Publishing; Treasure Island, FL, USA: 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">31613449</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour C.W., Liu V.X., Iwashyna T.J., Brunkhorst F.M., Rea T.D., Scherag A., Rubenfeld G., Kahn J.M., Shankar-Hari M., Singer M., et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3): For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:762–774. doi: 10.1001/jama.2016.0288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0288</ArticleId><ArticleId IdType="pmc">PMC5433435</ArticleId><ArticleId IdType="pubmed">26903335</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey A.S. Defining AKD: The Spectrum of AKI, AKD, and CKD. Nephron. 2022;146:302–305. doi: 10.1159/000516647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000516647</ArticleId><ArticleId IdType="pubmed">34167119</ArticleId></ArticleIdList></Reference><Reference><Citation>Robin X., Turck N., Hainard A., Tiberti N., Lisacek F., Sanchez J.-C., Müller M. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77. doi: 10.1186/1471-2105-12-77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-12-77</ArticleId><ArticleId IdType="pmc">PMC3068975</ArticleId><ArticleId IdType="pubmed">21414208</ArticleId></ArticleIdList></Reference><Reference><Citation>Therneau T. Package for Survival Analysis in R. R Package Version 3.2-7.  [(accessed on 16 December 2021)].  Available online:  https://cran.r-project.org/web/packages/survival/index.html.</Citation></Reference><Reference><Citation>Hothorn T., Hornik K., A van de Wiel M., Zeileis A. A Lego System for Conditional Inference. Am. Stat. 2006;60:257–263. doi: 10.1198/000313006X118430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1198/000313006X118430</ArticleId></ArticleIdList></Reference><Reference><Citation>Schratz P. R Package ‘Oddsratio’: Odds Ratio Calculation for GAM(M)s &amp; GLM(M)s. Version 1.0.2. 2017.  [(accessed on 12 October 2024)].  Available online:  https://zenodo.org/records/1095473.</Citation></Reference><Reference><Citation>Duca A., Piva S., Focà E., Latronico N., Rizzi M. Calculated Decisions: Brescia-COVID Respiratory Severity Scale (BCRSS)/Algorithm. Emerg. Med. Pract. 2020;22:CD1–CD2.</Citation><ArticleIdList><ArticleId IdType="pubmed">32297727</ArticleId></ArticleIdList></Reference><Reference><Citation>King J.T., Yoon J.S., Rentsch C.T., Tate J.P., Park L.S., Kidwai-Khan F., Skanderson M., Hauser R.G., Jacobson D.A., Erdos J., et al. Development and validation of a 30-day mortality index based on pre-existing medical administrative data from 13,323 COVID-19 patients: The Veterans Health Administration COVID-19 (VACO) Index. PLoS ONE. 2020;15:e0241825. doi: 10.1371/journal.pone.0241825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241825</ArticleId><ArticleId IdType="pmc">PMC7657526</ArticleId><ArticleId IdType="pubmed">33175863</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodacre S., Thomas B., Sutton L., Burnsall M., Lee E., Bradburn M., Loban A., Waterhouse S., Simmonds R., Biggs K., et al. Derivation and validation of a clinical severity score for acutely ill adults with suspected COVID-19: The PRIEST observational cohort study. PLoS ONE. 2021;16:e0245840. doi: 10.1371/journal.pone.0245840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245840</ArticleId><ArticleId IdType="pmc">PMC7822515</ArticleId><ArticleId IdType="pubmed">33481930</ArticleId></ArticleIdList></Reference><Reference><Citation>Quisi A., Alıcı G., Harbalıoğlu H., Genç Ö., Er F., Allahverdiyev S., Yıldırım A., Kurt İ. The CHA2DS2-VASc Score and In-Hospital Mortality in Patients with COVID-19: A Multicentre Retrospective Cohort Study. Arch. Turk. Soc. Cardiol./Türk Kardiyoloji Derneği Arşivi. 2020;48:656–663. doi: 10.5543/tkda.2020.03488.</Citation><ArticleIdList><ArticleId IdType="doi">10.5543/tkda.2020.03488</ArticleId><ArticleId IdType="pubmed">33034573</ArticleId></ArticleIdList></Reference><Reference><Citation>Caro-Codón J., Lip G.Y.H., Rey J.R., Iniesta A.M., O Rosillo S., Castrejon-Castrejon S., Rodriguez-Sotelo L., Garcia-Veas J.M., Marco I., A Martinez L., et al. Prediction of thromboembolic events and mortality by the CHADS2 and the CHA2DS2-VASc in COVID-19. EP Eur. 2021;23:937–947. doi: 10.1093/europace/euab015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euab015</ArticleId><ArticleId IdType="pmc">PMC7928912</ArticleId><ArticleId IdType="pubmed">33564822</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunduz R., Yildiz B.S., Ozdemir I.H., Cetin N., Ozen M.B., Bakir E.O., Ozgur S., Bayturan O. CHA2DS2-VASc score and modified CHA2DS2-VASc score can predict mortality and intensive care unit hospitalization in COVID-19 patients. J. Thromb. Thrombolysis. 2021;52:914–924. doi: 10.1007/s11239-021-02427-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-021-02427-1</ArticleId><ArticleId IdType="pmc">PMC7970772</ArticleId><ArticleId IdType="pubmed">33730303</ArticleId></ArticleIdList></Reference><Reference><Citation>Abacioglu O.O., Yildirim A. The ATRIA score is superior to the m-CHA2DS2-Vasc score in predicting in-hospital mortality in COVID-19. Rev. Assoc. Med. Bras. 2021;67:443–448. doi: 10.1590/1806-9282.20200983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1806-9282.20200983</ArticleId><ArticleId IdType="pubmed">34468612</ArticleId></ArticleIdList></Reference><Reference><Citation>Katkat F., Karahan S., Varol S., Kalyoncuoglu M., Okuyan E. Mortality prediction with CHA2DS2-VASc, CHA2DS2-VASc-HS and R2CHA2DS2-VASc score in patients hospitalized due to COVID-19. Eur. Rev. Med. Pharmacol. Sci. 2021;25:6767–6774. doi: 10.26355/eurrev_202111_27121.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202111_27121</ArticleId><ArticleId IdType="pubmed">34787881</ArticleId></ArticleIdList></Reference><Reference><Citation>Cetinkal G., Kocas B.B., Ser O.S., Kilci H., Keskin K., Ozcan S.N., Verdi Y., Zeren M.I., Demir T., Kilickesmez K. Assessment of the Modified CHA2DS2VASc Risk Score in Predicting Mortality in Patients Hospitalized With COVID-19. Am. J. Cardiol. 2020;135:143–149. doi: 10.1016/j.amjcard.2020.08.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2020.08.040</ArticleId><ArticleId IdType="pmc">PMC7453224</ArticleId><ArticleId IdType="pubmed">32861734</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X., Levine G.N., Birnbaum Y. The CHA 2 DS 2 -VASc score: Not as simple as it seems. Int. J. Cardiol. 2018;257:92–96. doi: 10.1016/j.ijcard.2017.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2017.12.027</ArticleId><ArticleId IdType="pubmed">29506745</ArticleId></ArticleIdList></Reference><Reference><Citation>Shroff G.R., Solid C.A., Herzog C.A. Atrial Fibrillation, Stroke, and Anticoagulation in Medicare Beneficiaries: Trends by Age, Sex, and Race, 1992–2010. J. Am. Heart Assoc. 2014;3:e000756. doi: 10.1161/JAHA.113.000756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.113.000756</ArticleId><ArticleId IdType="pmc">PMC4309061</ArticleId><ArticleId IdType="pubmed">24895161</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G., Greco M., Zanella A., Albano G., Antonelli M., Bellani G., Bonanomi E., Cabrini L., Carlesso E., Castelli G., et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern. Med. 2020;180:1345–1355. doi: 10.1001/jamainternmed.2020.3539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.3539</ArticleId><ArticleId IdType="pmc">PMC7364371</ArticleId><ArticleId IdType="pubmed">32667669</ArticleId></ArticleIdList></Reference><Reference><Citation>Çiçek V., Çınar T., Hayıroglu M.İ., Kılıç Ş., Asal S., Yavuz S., Selçuk M., Orhan A.L. Prognostic performance of CHA2DS2-VASc scores for predicting mortality among COVID-19 patients: A single pandemic center experience. Am. J. Emerg. Med. 2021;45:635–637. doi: 10.1016/j.ajem.2020.11.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.11.026</ArticleId><ArticleId IdType="pmc">PMC7673227</ArticleId><ArticleId IdType="pubmed">33234357</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavazzi G., Pellegrini C., Maurelli M., Belliato M., Sciutti F., Bottazzi A., Sepe P.A., Resasco T., Camporotondo R., Bruno R., et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur. J. Heart Fail. 2020;22:911–915. doi: 10.1002/ejhf.1828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1828</ArticleId><ArticleId IdType="pmc">PMC7262276</ArticleId><ArticleId IdType="pubmed">32275347</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonsoz M.R., Alp M.E., Guven G., Guler A., Unsel M., Aydin O.A. Increasing modified CHA2DS2-VASc risk score is associated with acute cardiac injury in hospitalised COVID-19 patients. Acta Cardiol. 2021;77:1–7. doi: 10.1080/00015385.2021.1952000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00015385.2021.1952000</ArticleId><ArticleId IdType="pubmed">34275416</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H., Hou K., Xu R., Li Z., Fu H., Wen L., Xie L., Liu H., Selvanayagam J.B., Zhang N., et al. Clinical Characteristics and Risk Factors of Cardiac Involvement in COVID-19. J. Am. Hear. Assoc. 2020;9:16807. doi: 10.1161/JAHA.120.016807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.016807</ArticleId><ArticleId IdType="pmc">PMC7726994</ArticleId><ArticleId IdType="pubmed">32806998</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghmousavi S., Rezaei N. COVID-19 infection and stroke risk. Rev. Neurosci. 2020;32:341–349. doi: 10.1515/revneuro-2020-0066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2020-0066</ArticleId><ArticleId IdType="pubmed">33580645</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo W., Liu X., Bao K., Huang C. Ischemic stroke associated with COVID-19: A systematic review and meta-analysis. J. Neurol. 2022;269:1731–1740. doi: 10.1007/s00415-021-10837-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10837-7</ArticleId><ArticleId IdType="pmc">PMC8517946</ArticleId><ArticleId IdType="pubmed">34652503</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Mitri C., Arcoleo G., Mazzuca E., Camarda G., Farinella E.M., Soresi M., Carroccio A., Imusg O.B.O.T. COVID-19 and non–COVID-19 pneumonia: A comparison. Ann. Med. 2021;53:2321–2331. doi: 10.1080/07853890.2021.2010797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2021.2010797</ArticleId><ArticleId IdType="pmc">PMC8648033</ArticleId><ArticleId IdType="pubmed">34854790</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadian E., Khatibi S.M.H., Soofiyani S.R., Abediazar S., Shoja M.M., Ardalan M., Vahed S.Z. COVID-19 and kidney injury: Pathophysiology and molecular mechanisms. Rev. Med. Virol. 2021;31:e2176. doi: 10.1002/rmv.2176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2176</ArticleId><ArticleId IdType="pmc">PMC7646060</ArticleId><ArticleId IdType="pubmed">33022818</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Wang X., Ren J., Sun Y., Yu R., Li K., Zheng L., Yang J. Risk factors and prognosis for COVID-19-induced acute kidney injury: A meta-analysis. BMJ Open. 2020;10:e042573. doi: 10.1136/bmjopen-2020-042573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-042573</ArticleId><ArticleId IdType="pmc">PMC7656886</ArticleId><ArticleId IdType="pubmed">33172950</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>